Eledon Pharmaceuticals's total assets for Q1 2026 were $146.67M, a decrease of -13.22% from the previous quarter. ELDN total liabilities were $46.21M for the fiscal quarter, a -47.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.